All posts by imreal

Health

Synthetic Fentanyl Crisis and Our Response

Leave a comment



EAST NORTHPORT, N.Y. (PRWEB)

Acutis Diagnostics Inc. announced that its most recent menu of synthetic fentanyl tests is the subject of a publication, “Urine Quantitative Analysis of 26 Novel fentanyl Analogs and Metabolites by LC-MS/MS and its Clinical Significance” and was presented as a poster at the 40th annual meeting of the American College of Toxicology (ACT). Additionally, the company announced that this work was accepted for publication in the International Journal of Toxicology in an upcoming issue during 2020. In the presentation, which was attended by both industry and as well as government officials, Acutis scientists outlined the research and development process they undertook to build and validate a comprehensive assay of more than two dozen analogs of fentanyl which were identified in clinical samples obtained from substance abuse facilities in the US.

“New forms of synthetic fentanyl are being introduced in the streets and often mixed with other substances. In many instances, we have observed that patients that were previously thought to be in compliance with their substance management programs were in fact utilizing certain forms of opioids that evaded detection by conventional means. After working with various agencies to identify the most prevalent forms of synthetic fentanyl, we then focused our efforts on the development of robust methodology by which we could identify and quantitate the levels of all of these compounds in a single assay with a total run time of under six minutes,” said Mumtaz Akhtar, Acutis Senior Scientist and lead author on the study.

The Acutis synthetic fentanyl assay identifies 26 of most common analogs of fentanyl as well as an additional three novel synthetic opioids (“Utopioids”) to provide an extensive menu of compounds that can detect highly dangerous substances that are in use. Such information provides clinicians with the ability to better monitor substance misuse that would otherwise go undetected. Moreover, many such patients were shown to be unwittingly using such drugs, a number of which can be lethal in amounts far less than common street drugs. “Our new synthetic fentanyl assay provides a comprehensive confirmatory drug assay that is capable of reducing the false negative rate that currently exists with less robust assays,” said Dr. Marjorie Bon Homme, Acutis’ Clinical Laboratory Director. “We are well positioned to provide an unsurpassed level of service to our substance use clientele who are increasingly trying to catch up to the wide array of street drug adulteration that is becoming more commonplace. We are also pleased to have presented our findings to concerned parties, such as the Drug Enforcement Agency, that have a shared goal to combat this public health crisis.”

For further information, please visit http://www.AcutisDiagnostics.com

Share article on social media or email:

Business: Insurance

Why Drivers Should Not Lie When Buying Car Insurance Online

Leave a comment


News Image

“Lying to your insurance company can only bring trouble. Be honest, even if this means paying a little more”, said Russell Rabichev, Marketing Director of Internet Marketing Company.


LOS ANGELES (PRWEB)

Applying for car insurance can be a nerve-wracking process. When the prices are higher than expected, many applicants feel frustrated. Some of them may try to hide the truth, in order to get better prices. But when the truth is uncovered, the insurance companies and authorities will react.

Car insurance companies don’t directly share information with one another. Instead, they subscribe to centralized data services, like specialty consumer reporting agencies. These companies provide nformation about a person’s driving record to the insurance companies. Through this system, insurance companies access common information about individual drivers, like recent claims. These include claims that did not result in a settlement and denied claims.


  •     Insurance companies usually discover the lies. One common lie is related to annual mileage. Some people present really low values, in order to get discounts. But when they take their cars in for an inspection or repairs, and the odometer reading doesn’t match the mileage the data given to insurance company, they will know you lied. That difference could be enough to trigger a further inspection of your insurance policy, and if it found that the policyholder lied about the mileage, the insurance company can cancel your policy.

  •     Insurance companies collaborate with each other. The reason is simple – they want to make sure they are not scammed by high-risk drivers. Another common lie is related to past traffic violations. Insurance companies have access to CLUE reports (Comprehensive Loss Underwriting Exchange). This report contains claim information provided by insurance agencies. So, if a person tells that he was not involved in an accident for the past 5 years, but a CLUE report created by a previous insurer shows a recent history of claims, the company will know that person is lying.

  •     Insurance contracts can be voided. Depending on the severity of the lie, the company can decide to void the contract. Naturally, if the driver does not switch immediately, he will also have a coverage lapse. This also can happen when making a claim, and the company will discover the problems. The claim will be denied and the policyholder will have to pay for everything.

  •     Expect rates to be increased for a long time. Being caught lying has really unpleasant consequences. In almost all cases, the first penalty is having the premiums increased. And there are likely to continuously increase with each renewal, for several consecutive renewals

Policyholders can be accused of fraud. Some “lies” are considered frauds. Fronting is the most common one. The consequences can even include the auto insurance provider taking the driver to the court which could result in jail time.

Cheapquotesautoinsurance.com is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

For more information, please visit http://cheapquotesautoinsurance.com

Share article on social media or email:

Health

ACC Medlink Purchases Three New Mercedes Sprinters For 2020

Leave a comment


ACC Medlink’s New Look Mercedes Sprinter Van!


PUNTA GORDA, Fla. (PRWEB)

ACC Medlink has purchased three 2020 Mercedes Sprinters that will be added to the already immense fleet of long distance medical transport vehicles. These vehicles will help add to an already “Green” fleet. “We’re excited to retire one of our longest running medical transport vehicles that has officially accumulated over one million miles. It will be replaced by one of the three new vehicles we’ve purchased. We are recognized as the largest Non-Emergency Medical Transportation company in the U.S.” said Michael Peat, CEO.

ACC has been providing long distance medical transportation to thousands of customers over the last 12 years. Their fleet is available 24/7 in every city and state across the contiguous U.S. for state to state medical transportation. Similar to how a hospital will upgrade their equipment, they feel it’s necessary to upgrade the transportation vehicles when the time comes. ACC Medlink strives to put safety and comfort above all else. The 2020 Mercedes Sprinter has the BlueTEC system which was created to improve vehicle performance and economy while lowering emissions. One of the BlueTEC components include AdBlue, which is a liquid solution injected into the exhaust. “When this is done, the liquid converts nitrogen oxide emissions into harmless nitrogen and oxygen, greatly reducing the emissions output”. These vehicles are incredibly spacious and have the feel of luxury, while also being better for the environment. Some companies utilize recreation vehicles (RVs) for their long distance medical transport, and these vehicles have higher emissions and are proven unsafe when compared to ACC’s fleet of vehicles.

Fuel economy, with a focus on green emissions, seems like it might only be beneficial to ACC Medlink, but it’s helpful for the patient on board. The goal is a safe and quick transport to their destination. The BlueTEC Clean Diesel technology helps make this a reality. “Almost every BlueTEC equipped vehicle offers a fuel economy that is six to eight miles per gallon better than equivalent gasoline-powered vehicles”. This allows for less gas-stops and more on-road time.

ACC Medlink makes modifications to the entire inside of the van for complete comfort during the long distance transport. Three beds and two captains chairs are in the back so multiple passengers can accompany their loved ones. An inspection service runs a crash simulation on the structural integrity of the materials used inside of the Mercedes Sprinter. They check the strength of the bed-plate welding, fittings, chairs, and other items in the back of the van. The goal of the inspections are to ensure that the modifications provide the safest possible vehicle for ACC Medlink customers. Since safety is the number one priority, they take the extra steps to ensure the safety of all passengers aboard their medical transport vehicles. ACC Medlink can be contacted at 1-800-550-1025.

Share article on social media or email:

Science: Biology

Futurist Betting On Anti-Aging Stem Cells Pens “New Breed of Homo Sapiens”

Leave a comment



LOS ANGELES (PRWEB)

Anti-aging therapies are a new emerging era of science that seem to benefit society using the power of stem cells, cytokines, and growth, regenerative, and life-extending factors. Regenerative therapies and exogenous stem cell transplantation into damaged tissues will also improve the wear and tear of aging.

New Breed of Homo Sapiens paves the way for revolutionary stem cell treatments that could vastly improve health in the twilight years. The contemporary series of books could be the key to understanding how the aging process works.

The multifaceted award-winning and internationally known author, Lou Baron is able to address one of the first questions individuals contemplating stem cell therapy for aging may have, “Could stem cells be the Holy Grail of medicine?”

Lourdes takes the battle against aging to of all places; stem cell therapy, with the expectation that scientists will master the technique of using stem cells to retard the aging process.

Researchers hope the results will lead to new, ‘personalized medicine’ approaches to the unfolding of slowing the aging process.

As humans, we persist in being baffled by the steady aging of our bodies, which sometimes seems to occur at a faster rate than we might expect. Consequently, we often do our best to try to stall or cheat the process, using a wide range of remedies, from improving our diets to undergoing plastic surgery.

Today, researchers are looking into how stem cells found in a region of our brain called the hypothalamus might play a key role in how swiftly we age. Dr. Dongsheng Cai, from the Albert Einstein College of Medicine, in New York City, New York, alongside a team of specialists, have found that adding fresh stem cells to the hypothalamus might be the way to go if we want to delay old age.

Ground breaking studies like these have already shown that the hypothalamus does in fact play a crucial role in controlling aging. Stem cells in the brain determine how quickly our bodies debilitate, researchers have noted. But, by introducing fresh stem cells, part of the aging process could be slowed down or reversed.

New Breed of Homo Sapiens outlines a range of topics that analyze and expound on human aging and the various disorders associated with the natural biological process. While dealing with an immensely scientific subject, Lou Baron, leaves the beaten path and instead addresses her readers in clear, in-depth and easy to follow directive.

“I want my readers to fully understand and grasp the importance of this medical breakthrough,” she said. “We are talking about the future generations and the new breed of humans, and I want to bring the knowledge to the public’s door step,” she added.

Lou Baron, at 72 years young, is a sprightly, vivacious woman, defying her age – she credits stem cells. “I am living proof that stem cell based therapy really works.” Elucidating how this was the spark that brought about the idea to write, New Breed of Homo Sapiens.

“Stem cells will reverse aging and improve the quality of life for many, but it is not a ticket to immortality,” Baron noted.

The Feeling Good At Any Age crooner, reinvented by the experience that delivers the kind of energy and fearlessness that made her successful as a singer, to an entirely different issue, with huge effect. “Stem cells hold enormous promise, the potential to overcome age related deterioration of the body in regenerative medicine is astounding, something we must pursue,” the author said in a recent interview.

Baron has studied tirelessly to research and promote advances in stem cell research. “We need to do more,” she said. “Let’s continue to take risks. Let’s tackle the issues. In ways our music and film communities can do it better than anyone else. There is no challenge, artistic or otherwise, that we can’t meet,” she added.

Baron provides hope, inspiration and unclouded steps on confronting the aging process. Her greatest role may be as champion for baby boomers – an advocate of stem cell therapy.

As reported in Nature:

New research reveals how increasing brain stiffness as we age causes brain stem cell dysfunction, and demonstrates new ways to reverse older stem cells to a younger, healthier state.

The results have far-reaching implications for how we understand the aging process, and how we might develop much-needed treatments for age related brain diseases.

As our bodies age, muscles and joints can become stiff, making everyday movements more difficult. This study shows the same is true in our brains, and that age-related brain stiffening has a significant impact on the function of brain stem cells.

A multi-disciplinary research team, based at the Wellcome-MRC Cambridge Stem Cell Institute (University of Cambridge), studied young and old rat brains to understand the impact of age-related brain stiffening on the function of oligodendrocyte progenitor cells (OPCs).

These cells are a type of brain stem cell important for maintaining normal brain function, and for the regeneration of myelin — the fatty sheath that surrounds our nerves, which is damaged in multiple sclerosis (MS). The effects of age on these cells contributes to MS, but their function also declines with age in healthy people.

To determine whether the loss of function in aged OPCs was reversible, the researchers transplanted older OPCs from aged rats into the soft, spongy brains of younger animals. Remarkably, the older brain cells were rejuvenated, and began to behave like the younger, more vigorous cells.

Could stem cell based therapies be the answer to unleashing the New Breed of Homo Sapiens?

Discover the answers in this exciting treatise, set for release, the spring of 2020.

Excerpts from New Breed of Homo Sapiens.

Stem Cells Determine Man’s Biological Age

Aging is a biological process that affects all living organisms. However, while the questions of why and how we age have baffled scientists for decades, the field of aging and longevity research have stayed in the back-burner for many years until not too long ago when it attracted the attention of some of the world’s most serious scientists. Today, medicines and therapies aimed at slowing down the process of aging and targeting age-related diseases are being developed, with some already launched in clinical trials in humans.

Aging is associated with the decline of all the physical and biological processes and functions over time. With the aim of slowing down the aging process, scientists have turned to studying stem cells for their regenerative abilities. However, while stem cells over potential solutions to retard or reverse the aging process, they also appear to be either the cause or part of the problem that cause aging. Stem cells, which are essential parts of the body’s repair system due to their ability to differentiate into many other cell types, lose their regenerative potency as our body ages. Additionally, their self-renewing ability triggers mutations that affect every cell in the body. And once these mutations accumulate they can lead to disease.

With money and investments continuously pouring in, the field of stem cell biology is still developing. However, focus has veered away from what scientists thought was stem cells greatest promise: that their ability to grow replacement organs and tissues that are damaged due to diseases or injuries. Today focused has shifted dramatically and researchers are now harnessing stem cells for their potentially powerful uses in modeling disease for drug discovery as well as in targeting treatment for personalized medicine. Using easily accessible cells – such as skin or blood – from the sick, researchers are reprogramming them into the affected tissue types and using them as models to study the disease and test interventions on major disorders, including heart disease, stroke, diabetes, and cancer, as well as rare conditions such as amyotrophic lateral sclerosis (ALS).

In addition, knowledge of stem cell biology is continuously evolving. Previous understanding was that once embryonic stem cells has differentiated into stem cells for muscle, skin, blood, and other tissue, those stem cells maintain their flexibility to further develop into various cells within the tissue, when required. Recent works, however, indicate that this ability may be more limited, with different stem cells possessing different capabilities, and or their capabilities diminished with age. If this were the case, then this would probably explain why aging varies from person to person. But the science of stem cell research is evolving, disease profiles are changing, and the tools of knowledge of physicians are readily at their disposal, more powerful and targeted. It would not be a far-fetched idea that one day the full potential of stem cell science will transform our biological landscape and the way humans develop and grow old.

Anti Aging and Stem Cells

A little over two decades ago, Dr. Michael West, stumbled upon a major scientific breakthrough when his lab scientists successfully isolated the active component for the gene that confers immortality to cells: the telomerase. Fast forward to today, when a new field has emerged: the science of longevity and healthspan, when people can live longer, free of age related diseases. Backed with substantial investments from some of the world’s largest companies, numerous pre-clinical researchers are developing and various clinical trials are underway, with the aim of developing therapeutics to target human aging and age related disorders.

While the biggest challenge for the field is the complexity of the aging process, scientists are making great progress in the context of individual aspects of aging with some of the most promising areas of research and discoveries in aging, which we are highlighting below:

Pluripotent stem cells have paved the way to manufacture young cells and tissue of any kind. Twenty years after the isolation of the first human embryonic stem cells, there is an explosion of research and applications all aimed at making different cell types of the human body.

Early human development could be the key that will unlock the mystery of aging. Cells possesses not only the ability to replicate, but to regenerate. There are animals in nature whose regenerative ability is never turned off — like the flatworm, which can grow back it’s head if it gets cut off, and it doesn’t show signs of aging either. Discovering and undertstanding how the cells regeneration ability gets turned on or off may unlock this mystery.

Companies are pouring in their resources into anti-aging research. Major companies are investing heavily in anti-aging research with the aim of devising interventions to slow down the aging process. Some of these companies are AgeX, a subsidiary of BioTime, Calico, AbbVie Inc., Unity Biotechnology, Samumed, Human Longevity Inc., RestorBio, Rejuvenate Bio, and Juvenescence, among others.

The majority of clinical applications will not be happening soon. However, despite the mad rush to develop potentially beneficial interventions, majority of these applications will require years of clinical trials before they can be made available to the populace.

There are very few medical interventions that are proven to slow the aging proves today. Because there is a huge marketplace out there, there are companies with claims of stem cell products that will extend your life. However, it is important to understand that they are likely not based on pluripotent stem cell technology or are products which are not approved by the FDA.

Ethical issues still hound this new science. Could genetic engineering be used one day to program longer lifespans by modifying or reprogramming human embryos? Despite advances in technology, people should take note that there remain major ethical issues regarding interventions aimed to prolong life. Dr. Michael West said that while it is entirely possible to engineer babies, but when you make modifications, it is an experiment, and you put a human life at risk.

Interventions in human aging face major cultural challenge. While aging affects all people of all races, we humans have adapted to the fact that death is part and the end of life, which people generally see as inevitable. This precept is anchored on different belief systems based on one’s culture and traditions.

Healthy children born today could enjoy a lifespan never before seen in human history. It is highly possible that in the foreseeable future, people will live up to at least 150 years of age. And as more advances and powerful therapies are designed and developed, the prospect of people enjoying longer and healthier lifespan is highly possible.

For more information and to reserve your copy, email: timelessentinc1@gmail.com

Business: Insurance

Compare-autoinsurance.org Presents Top Tips For Getting Cheap Car Insurance

Leave a comment


News Image

“Using online quotes or accessing various discounts will help drivers find better rates. Visit our website for free car insurance quotes”, said Russell Rabichev, Marketing Director of Internet Marketing Company.


LOS ANGELES (PRWEB)

Many drivers consider that car insurance is too expensive or they deny their importance. Disregarding a service that can potentially save drivers thousands of dollars is a huge mistake. If the price is the problem, check the following tips on getting cheaper car insurance.

Find out more and get free quotes from https://compare-autoinsurance.org/lower-car-insurance-premiums/


  • Get access to as many discounts as possible. Insurance companies pride themselves on offering the best discounts on the market. Carefully analyze the discounts offered by each company before signing a contract. When getting online quotes, the user can easily check for how many discounts he is eligible and how much he will save. The most common discounts include low mileage, safety devices, homeownership, and paying-in-full.

  • Try to pay-in-full. Drivers are asked how many payments do you want to make. Paying for the entire policy in advance will help drivers save a lot of money. The driver can save around 5%-10% just by paying the full value.

  • Increase the value of deductibles. Modifying the deductibles is also a factor under the client’s control. By selecting a higher deductible level, he will assume more financial responsibility, should he need to make a claim. Deductibles range from $250 up to $1000 or more. In many cases, the recommended value for both comprehensive and collision coverage is $500. When getting online quotes, the client is able to set the deductibles to some predetermined values. The price will be updated after each deductible modification.

  • Bundle policies under the same insurer. Placing multiple vehicles or multiple belongings (like a home) under the same insurer can bring numerous benefits. Besides having access to discounts, the policyholder will only have to deal with just one single contract and pay one bill. Multi-insurance discounts vary by provider, with some companies offering as much as 20% discount.

  • Ask about loyalty discounts. Some insurers will approach the policyholder to offer loyalty discounts. With other insurers, however, the client must ask about this feature. Tell the insurer that you’ve received a better quote from another insurance company, but mention that you don’t want to make the switch because you’ve been a happy customer for many years. Sometimes, they’ll offer a small discount as a reward or at least match the competing offer.

  • Senior drivers should take a refresher course. To encourage driver safety, insurance companies often provide discounts to older drivers who take a refresher course. These courses can help older drivers get up-to-date on the technology in new cars, as well as any new road signs, driving strategies, or recently-introduced driving systems.

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

For more information, please visit http://compare-autoinsurance.org

Share article on social media or email:

Business: Executives

blumshapiro Announces Heather B. Bearfield Appointed Partner in Advisory Services Group

Leave a comment


Joseph Kask, Chief Executive Officer, blumshapiro.

“We are pleased to have Heather join our Advisory Services team. Heather brings a strategic, results-driven skillset and a proven track record in helping businesses enhance their risk capabilities,” said Joseph Kask, chief executive officer of blumshapiro.


WEST HARTFORD, Conn. (PRWEB)

blumshapiro, the largest accounting, tax and business advisory firm based in New England with offices in Connecticut, Massachusetts and Rhode Island, announced today that Heather B. Bearfield has joined blum’s Advisory Services Group as a partner. She will be based out of blum’s Boston, Massachusetts office beginning December 2019.

Bearfield has more than 15 years of experience in leadership roles managing risk and building information security management programs. Heather has extensive experience in IT Risk Management Consulting, Information Security Governance, Corporate IT Audit and Corporate Operational Risk functions. In her new role, she will serve as a blum Partner for Cyber and IT Risk Services. She will be responsible for managing risk and building information security management programs for blum clients.

“We are pleased to have Heather join our Advisory Services team. Heather brings a strategic, results-driven skillset and a proven track record in helping businesses enhance their risk capabilities. She has been extremely successful in building best practice IT governance, risk and cybersecurity control management tools and processes and is fully committed to blum’s focus on enhancing client value,” said Joseph Kask, chief executive officer of blumshapiro.

“Joining blumshapiro is a wonderful opportunity for me to bring my extensive cyber and IT risk management skills to a firm focused on expanding its advisory services throughout the Northeast and beyond. I look forward to working with forward-thinking, experienced professionals focused on providing clients with world-class expertise in the ever-growing area of global security and intelligence,” said Bearfield.

Prior to joining blumshapiro, Bearfield served as Principal of Cyber and IT Risk Services, National Service Line Leader at Marcum LLP based in Boston. Bearfield has a record of performance, reliability and success at identifying process and control weaknesses, analyzing complex systems and working with clients to streamline operations. A sought-after speaker for many industry events, Bearfield led global and nationwide IT assessments in numerous vertical markets inclusive of manufacturing, banks, financial services, colocation hosting facilities and application service providers. She previously led a security practice involving the execution of Internal/External Vulnerability Assessments, Penetration Testing, Wireless Assessments and Social Engineering.

Bearfield’s professional affiliations include membership in the Information Systems Auditing and Control Association, the Institute of Internal Auditors, Cambridge’s Who’s Who, the Boston Chamber of Commerce Women’s Advisory Board and Nichols’ College Board.

Bearfield is also a national leader in diversity and inclusion programs and has helped develop the Women’s Initiative and Diversity Awareness, among others.

Bearfield received her Masters of Business Administration in 2001 from the University of Vermont (UVM) School of Business and a Bachelor of Science in Business Administration in 2000 from UVM.

She is resides in Hopkinton, Massachusetts.

blumshapiro is the largest regional business advisory firm based in New England, with offices in Connecticut, Massachusetts and Rhode Island. The firm, with a team of over 500, offers a diversity of services which include auditing, accounting, tax and business advisory services. blum serves a wide range of privately held companies, government and nonprofit organizations and provides non-audit services for publicly traded companies. To learn more visit us at blumshapiro.com.

Share article on social media or email:

Health

Primary Residential Mortgage, Inc. Partners with MBA Opens Doors Foundation

Leave a comment


News Image

“MBA Opens Doors initiative mirrors PRMI’s belief that everyone deserves a home. We’re both continuing to help ensure families in need and dealing with unexpected challenges don’t have to worry about losing their home,” said Chief Production Officer, Tom George.


SALT LAKE CITY (PRWEB)

Primary Residential Mortgage, Inc. (PRMI) announced at its October 2019 National Conference their partnership with the Mortgage Bankers Association (MBA) to raise donations for the MBA Opens Doors Foundation.

The organization pledged to match funds donated from its branch partners across the country through the end of 2019. PRMI branch partners raised a total of $19,814.20, resulting in an additional $20,000 match from the company, making the grand total donation to MBA Opens Doors Foundation $39,814.20.

“To have the support of companies like PRMI means that families facing one of the worst crises in their lives can focus on the health of their child and not on a home in jeopardy.” said Deborah Dubois, president of the MBA Opens Doors Foundation. “We are profoundly grateful for PRMI’s support.”

The MBA Opens Doors Foundation helps families caring for critically ill children by providing assistance grants to pay their mortgage or rent payments. Many of these families spend months at the hospital with their children, often taking unpaid leave to do so. The MBA Opens Doors Foundation ensures they have a place to come home to when they’re able.

“MBA Opens Doors initiative mirrors PRMI’s belief that everyone deserves a home. We’re both continuing to help ensure families in need and dealing with unexpected challenges don’t have to worry about losing their home,” said Chief Production Officer, Tom George. “Like the MBA Opens Doors program, our team members work hard every day to change people’s lives and communities for the better by providing selfless service.”

Primary Residential Mortgage, Inc. (PRMI) is a nationwide, multibillion-dollar operation cofounded in 1998 by Dave Zitting, Jeff Zitting and Steve Chapman. Its top leaders are authorities in the mortgage industry. With over 240 branches, licensed in 49 states and more than 1,800 employees, PRMI has been repeatedly recognized as a top mortgage lender and was recently inducted into the 2018 Ellie Mae Hall of Fame for Excellence in Compliance. For more information, call 800-255-2792 ext. 1000252, visit

http://www.primaryresidentialmortgage.com, or follow us on LinkedIn, Twitter and Facebook. PRMI is an Equal Housing Lender. NMLS #3094.

Corporate Contact

Maddi Hardy

Public Relations Coordinator

mhardy@primeres.com

1.800.255.2792

Share article on social media or email:

Business: Executives

Tim Conkle of The 20 celebrates milestone with Forbes Technology Council

Leave a comment


Tim Conkle | The 20 | Forbes Technology Council

“I am honored to have the opportunity to collaborate, share best practices and contribute with my peers in the Forbes community,” said Conkle.


PLANO, Texas (PRWEB)

Tim Conkle, CEO of The 20, is celebrating his one-year anniversary as a member of the Forbes Technology Council, an invitation-only organization for senior leaders to publish original content, connect and excel.

“We are so pleased to have Tim Conkle entering year two as a member of Forbes Technology Council,” said Scott Gerber, founder and CEO of Forbes Councils. “Our mission with Forbes Councils is to bring together proven leaders from every industry, creating a curated, social capital-driven network that helps every member grow professionally and make an even greater impact on the business world, and Tim is an important part of that community.”

“Contributing to the Forbes Technology Council and connecting with other industry leaders has been an invaluable experience. I am honored to have the opportunity to collaborate, share best practices and contribute with my peers in the Forbes community. Having served the industry for a long time, the values of the community are in perfect alignment with The 20’s dedication to making a powerful impact through intelligent connections,” said Tim Conkle.

Tim Conkle’s past contributions to Forbes, as well as his contributions to a variety of other media outlets, can be viewed on The 20 Press page. His executive profile is also available on Forbes.

ABOUT FORBES COUNCILS

Forbes Councils is a collective of invitation-only communities created in partnership with Forbes and the expert community builders who founded Young Entrepreneur Council (YEC). In Forbes Councils, exceptional business owners and leaders come together with the people and resources that can help them thrive. More information is available at forbescouncils.com.

ABOUT THE 20

The 20 is an exclusive consortium for Managed Service Providers (MSPs) aimed at dominating and revolutionizing the IT industry with its standardized all-in-one approach. The 20’s robust RMM, PSA, and documentation platform ensures superior service for MSP clients utilizing their completely US-based Help Desk and Network Operations Center. Extending beyond cutting-edge tools and processes, The 20 touts a proven sales model, a community of industry leaders, and ultimate scalability. For more information, visit: http://www.the20.com.

Share article on social media or email:

Health

After Winning Prestigious Technology Award, InfoBionic Looks Ahead to 2020

Leave a comment


InfoBionic was awarded the 2019 Frost and Sullivan North American Award

MoMe Kardia puts the patient at the center of the digital ecosystem, non-intrusively recording, storing, and analyzing cardiac activity—virtually bringing the patient closer to the physician.


WALTHAM, Mass. (PRWEB)

InfoBionic, a digital health company headquartered in Waltham, Mass., claimed the esteemed 2019 Frost and Sullivan North American Remote Cardiac Monitoring Technology Leadership Award for its MoMe Kardia product, the only full-disclosure remote monitor currently on the market that allows doctors immediate and 24/7 access to cardiac data on demand. The award represented formal recognition of the company’s success in 2019, which was bolstered by the myriad enhancements made to its flagship product, which was already cutting edge.

“The award is given to the company that shows the greatest commitment to innovation and creativity, operational efficiency, growth potential, technological leverage and business impact,” said Frost & Sullivan Senior Research Analyst Debarati Sengupta. “Ultimately, success is measured by the degree to which a technology is leveraged and the impact that technology has on growing the business.”

The MoMe Kardia captures a clinical-grade electrocardiogram (ECG) and delivers continuous cardiac monitoring in near real time, which the physician can access on his or her tablet, smartphone, or on any Internet-connected computer. Many older technologies require that cardiac patients in distress press a button or key (referred to as “self-activation”) to relay their cardiac readings to the physician. The MoMe Kardia requires no such intervention. The patient needs merely to go about his or her day; the technology does the rest.

In addition to improving patient outcomes, some studies have already demonstrated a significant cost savings that can be realized with remote cardia monitoring; “Remote patient monitoring and patient-generated health data from monitoring devices contribute to valuable clinical, financial, and operational returns on investment (ROI),” according to a July 2018 report.

The MoMe Kardia also boasts enormous gains in the area of data retention. Studies show that legacy systems lose 95 percent to 99 percent of cardiac data.

Independent diagnostic and testing facilities servicing monitors might transmit a 30-second tape of a detected arrhythmia, but doctors frequently miss crucial onset and offset data in the moments prior, losing a key piece of vital data. There is no such data loss with the MoMe Kardia.

Enhancements made to the MoMe Kardia product in 2019 demonstrate that InfoBionic is not resting on its laurels. They listened to cardiologists and electrophysiologists who explained their workflow in detail and how MoMe Kardia truly delivers the telemetry monitoring they need. The MoMe Kardia advisory board met quarterly in 2019 and is made up of InfoBionic customers across the country. They helped drive several of the product releases this year which included new functionality in the software as well as upgrades to the MoMe Kardia device.

Additional enhancements include supplementary views of the two channels the MoMe Kardia currently acquires, adding selectable leads III, aVr, aVf and aVl. This is called six-lead personal ECG monitoring and enables a cardiologist to select the lead best suited to assist in diagnosis.

“We’re very pleased with what we accomplished in 2019 and will continue to work for what we stand for,” said InfoBionic CEO Stuart Long. “That is the need in the remote cardiac monitoring industry for a cardiac monitor that integrates the positive attributes of the various form factors, while also keeping in mind evolving healthcare trends and patients’ increasing comfort with the digital space,” he said. “MoMe Kardia puts the patient at the center of the digital ecosystem, non-intrusively recording, storing, and analyzing cardiac activity—virtually bringing the patient closer to the physician.”

About InfoBionic

InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs have had successful careers in healthcare, IT, medical devices and mobile technology, and bring specific expertise in remote monitoring and cardiology. They have seen first-hand the complexities of traditional cardiac arrhythmia detection and monitoring processes and designed the transformative MoMe® Kardia platform to remove the roadblocks hindering faster, more effective diagnosis and decision-making. Frost & Sullivan bestowed the 2019 North American Remote Cardiac Monitoring Technology Leadership Award upon InfoBionic. For more information visit http://www.infobionic.com

About MoMe Kardia™

The company’s flagship product, the MoMe® Kardia 3-in1 monitor, is the first non-invasive remote cardiac monitor to offer truly full disclosure, heartbeat-to-heartbeat data over the Cloud, allowing doctors 24/7 real-time access to hospital telemetry-level data. With the MoMe® Kardia, doctors will be able to eliminate third-party monitoring data services and take full ownership of the cardiac monitoring process, empowering them to realize lucrative new revenue streams by billing globally for the monitoring service. MoMe® Kardia is not intended for use as an emergency medical response system. Call 911 if you feel you are having a medical emergency.

1.    “Remote Patient Monitoring Shows Significant ROI, Report Says,” Advanced Safety in Health Technology, September 2018

2.    Ibid.

                                                             # # #

Share article on social media or email:

Business: Executives

The Best Lawyers in America © 2020 Recognizes Attorney Thomas More Marrone for 8th Straight Year

Leave a comment


Attorney Tom Marrone being selected by his peers for inclusion in The Best Lawyers in America for 2020 marks the 8th consecutive year receiving this accolade.


PHILADELPHIA (PRWEB)

MOREMARRONE LLC is honored to announce that Thomas More Marrone has been selected by his peers for inclusion in The Best Lawyers in America for 2020. This marks the eighth consecutive year that Tom Marrone has been recognized by his peers and received this accolade. Thomas More Marrone has been selected by his peers for inclusion in The Best Lawyers in America© in the field of Personal Injury Litigation – Plaintiffs. This honor reflects the high level of respect attorneys have earned among their peers in their communities and respective practice areas for their abilities, professionalism, and integrity. Lawyers are not required or allowed to pay a fee to be listed; therefore, inclusion in Best Lawyers is considered a singular honor.

Since it was first published in 1983, Best Lawyers® has become universally regarded as the definitive guide to legal excellence. Best Lawyers lists are compiled based on an exhaustive peer-review evaluation. Almost 94,000 industry leading lawyers are eligible to vote (from around the world), and we have received over 11 million evaluations on the legal abilities of other lawyers based on their specific practice areas around the world. For the 2020 Edition of The Best Lawyers in America©, 8.3 million votes were analyzed, which resulted in more than 62,000 leading lawyers being included in the new edition. Lawyers are not required or allowed to pay a fee to be listed; therefore inclusion in Best Lawyers is considered a singular honor. Corporate Counsel magazine has called Best Lawyers “the most respected referral list of attorneys in practice.”

Best Lawyers is the oldest and most respected attorney ranking service in the world. For more than 30 years, Best Lawyers has assisted those in need of legal services to identify the attorneys best qualified to represent them in distant jurisdictions or unfamiliar specialties. Best Lawyers lists are published in leading local, regional and national publications across the globe. The Best Lawyers in America© recognizes the very best lawyers in each practice area and metropolitan region in the country.

About Thomas More Marrone and MOREMARRONE LLC:

MOREMARRONE LLC has handled cases producing some of the largest verdicts and settlements in Pennsylvania and New Jersey. The firm represents plaintiffs in significant personal injury, class action, and other complex civil litigation. After a recent 11-month stretch that included two class action jury trials resulting in a settlement and verdict amounting to well over $15 million in addition to several substantial personal injury recoveries, successful business and employment negotiations, and hundreds of satisfied clients, Tom Marrone established his multifaceted firm, MOREMARRONE LLC.

Licensed to practice in the State and Federal courts of Pennsylvania, New Jersey, and New York, Tom Marrone has extensive experience and proven success handling difficult, complex cases, especially class actions and collective actions, cases involving personal injury, employment, wage and hour claims, insurance matters, product liability, consumer protection, consumer fraud, deceptive practices, legal malpractice, and wrongful use of civil proceedings.

Individual and corporate clients also engage MOREMARRONE LLC for advisory services, including legal matters, crisis prevention and crisis management. A veteran class action trial lawyer, Tom Marrone also offers consultations with other attorneys and law firms related to class action and complex litigation theory development, implementation, and trial strategy.

Share article on social media or email: